Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$262.75 - $319.31 $168,422 - $204,677
641 New
641 $200,000
Q4 2023

Jan 25, 2024

BUY
$255.7 - $288.46 $184,359 - $207,979
721 New
721 $207,000
Q4 2022

Feb 07, 2023

BUY
$229.03 - $291.01 $189,407 - $240,665
827 New
827 $217,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Firethorn Wealth Partners, LLC Portfolio

Follow Firethorn Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Firethorn Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Firethorn Wealth Partners, LLC with notifications on news.